glp-1 kidney outcomes news today GLP therapies have established themselves as kidney-protective in type 2 diabetes and high risk of disease. This new post-hoc analysis of SURPASS-CVOT's kidney shows greater kidney protection with tirzepatide (#mounjaro) New meta-analysis: In > 7,000
Description
Orskov C, Poulsen SS, Morten M, Holst JJ
Patients should not rely on the medication alone
Newman, R
Healthy eating improves results
Reduce inflammation
Are in perimenopause or menopause : Hormonal shifts have changed how your body responds to diet and exercise
